Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Health Technology Assessment Goes Online

June 15, 2011

LONDON, June 15, 2011 /PRNewswire/ –

Pharma IQ is pioneering new HTA discussion platform with launch of the
first ever HTA Online event – Global HTA and CER Forum, which will take an
innovative form of 12 online session over the course of August.

Health Technology Assessment has recently observed an unprecedented
global expansion. Clinical and cost effectiveness are assessed for
pharmaceuticals in Australia, Canada and the UK, while clinical benefit is
the main focus in France and Germany for new drugs. CER is rapidly gaining
momentum in the US to inform federal funding decisions, while commercial US
payers use clinical and economic evidence in formulary listings.

Over 12 speakers from 10 countries, including 5 HTA agencies, will
deliver 13 presentations:

– National Institute for Health and Clinical Excellence (NICE)

– Patented Medicine Prices Review Board (PMPRB)

– Spanish Agency for Health Technology Assessment (AETS)

– Roche Products

– GlaxoSmithKline

– HIQA

– Office of Health Economics

– F. Hoffmann-La Roche

– Amgen

Key topics to discussed by expert panel include:

        - Speeding the reimbursement processes with first-hand input
          from prominent HTA bodies: NICE, OHE and HIQA
        - Exploring the efforts of standardisation of HTA in Europe

        - Implementing a best practice approach to value-based pricing

        - Analysing the finer points of performance-based
          reimbursement and its impact

        - Aligning HTA strategies with insight from leading pharma and
          biotech companies: GSK, Roche and Amgen

        - Designing product development programmes to maximise
          reimbursement success

The online form of the event is meant to help to reach the global
audience and enable experts from Europe to have a live discussion with their
colleagues in US, Canada and Australia without the need to leave their desk.

‘ In response to the fact that we operate in a time of reduced budgets
and time, this conference takes place 100% online, therefore no travelling
expenses or timing conflicts would occur’ says Andrea Charles, Global HTA
and CER Forum Director. ‘What’s more, if someone misses a session, it can
always be accesses online as a recorded version of live session. It also
means thatnow we can easily access global audience and industry experts from
United States will be able to network easily with their colleagues from
Europe without the need of leaving their desk or home’.

To find out more about how Global HTA and CER Forum plans to bring
together word-wide renowned experts in the field, or to join the online
discussion, visit the event website: http://www.htaforumonline.com

https://www.htaforumonline.com/?utm_campaign=PressReleasesbrochure&utm_medium=online&utm_source=Press_ReleasesBR&MAC=20511.001PR2

        For more information, images or press passes, contact:

        PHARMA IQ
        Joanna Checinska, Marketing Manager
        Email: joanna.checinska@iqpc.co.uk
        Phone: +44(0)2073689300

SOURCE Pharma IQ


Source: newswire